AU Patent

AU2007333377A1 — Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor

Assigned to Millennium Pharmaceuticals Inc · Expires 2008-06-19 · 18y expired

What this patent protects

Patent listed against Bevyxxa.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007333377A1
Jurisdiction
AU
Classification
—
Expires
2008-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Millennium Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.